Routed introductions between counterparties whose timing already aligns.
Inverto Group operates a private network across biotech, financial services, and lower middle-market transactions. We do not advise. We route — once, into a live situation, when both sides benefit.
One thing, narrowly: introductions between counterparties already converging on the same situation, made at the moment the situation is live.
Not advisory. Not brokerage. Not outreach at scale. We maintain a working view of capital, operators, and dealflow inside a small set of verticals, and we move once — when timing, intent, and alignment are real on both sides.
- 01Clinical-stage biotechs reporting under 24 months of cash runway against Phase 2 programs structurally requiring 30–39 months to readout
- 02Two broker-led mid-market deals stalled at the financing stage, seeking alternative capital
- 03Four lower middle-market acquisitions entering their financing window in the next 90 days
- 04One regional lender reactivating previously declined files in a constrained credit environment
Updated April 2026 · milos@inverto-group.com if any of these are yours
We work narrowly. Coverage is concentrated where the network is dense.
- BiotechClinical-stage operators, capital allocators, crossover investors
- Financial servicesRegional lenders, private credit, specialty finance
- Lower middle-market M&ASponsors, search funds, broker-led processes
- B2B servicesRegulated environments, enterprise sales motion
- Talent & placementsCompressed hiring cycles, leadership transitions
Observed across recent mandates, by sector.
- BiotechCrossover capital introduced inside a 60-day window pre-readout
- Private credit$100K+ in new revenue unlocked across a 90-day window
- M&A sponsorSix qualified introductions leading to active deal discussions
- TalentTwenty placements completed across a compressed hiring cycle
- Regulated B2BFour enterprise agreements formed in a regulated environment
- Services€70K generated within 90 days through direct introductions
Selected outcomes reflect observed movement across mandates and counterparties.
Most deals do not fail on merit. They fail because the right parties were not in the room at the moment the situation was live. Markets are constrained less by demand than by visibility and alignment — by who sees what, and when.
Our work begins from that premise. We track movement rather than intent, structure rather than sentiment, and we act only when timing makes an introduction useful to both sides.
Considered
- Firms in motion — funding, hiring, expansion, transactions
- Operators with active deal flow
- Situations in which timing materially affects outcome
Not considered
- Early-stage exploration
- General curiosity
- Volume-driven outreach
- Situations without clear intent or urgency